These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37900477)
1. Lower Prealbumin and Higher CRP Increase the Risk of Voriconazole Overexposure and Adverse Reactions. Lin L; Fu X; Hong M Cureus; 2023 Sep; 15(9):e46107. PubMed ID: 37900477 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with Voriconazole. Risum M; Vestergaard MB; Weinreich UM; Helleberg M; Vissing NH; Jørgensen R Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33922419 [TBL] [Abstract][Full Text] [Related]
4. A Large Sample Retrospective Study on the Distinction of Voriconazole Concentration in Asian Patients from Different Clinical Departments. Zhao Y; Xiao C; Hou J; Wu J; Xiao Y; Zhang B; Sandaradura I; Yan M Pharmaceuticals (Basel); 2021 Nov; 14(12):. PubMed ID: 34959640 [TBL] [Abstract][Full Text] [Related]
5. Effects of inflammation on voriconazole levels: A systematic review. Li X; Lai F; Jiang Z; Li M; Chen Z; Cheng J; Cui H; Wen F Br J Clin Pharmacol; 2022 Dec; 88(12):5166-5182. PubMed ID: 35973037 [TBL] [Abstract][Full Text] [Related]
6. Individualized Medication of Voriconazole: A Practice Guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. Chen K; Zhang X; Ke X; Du G; Yang K; Zhai S Ther Drug Monit; 2018 Dec; 40(6):663-674. PubMed ID: 30192314 [TBL] [Abstract][Full Text] [Related]
7. Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events. Huo BN; Shu L; Xiao JW; Yin NG; Ai ML; Jia YT; Song L Front Pharmacol; 2024; 15():1292163. PubMed ID: 39403147 [TBL] [Abstract][Full Text] [Related]
8. Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis. Yousefian S; Dastan F; Marjani M; Tabarsi P; Barati S; Shahsavari N; Kobarfard F Can J Infect Dis Med Microbiol; 2021; 2021():5497427. PubMed ID: 33953804 [TBL] [Abstract][Full Text] [Related]
9. A case-report of unpredictable and massive voriconazole intoxication in a patient with extensive CYP2C19 and CYP2C9 polymorphisms. Lemaitre F; Barbaz M; Scailteux LM; Uhel F; Tadié JM; Verdier MC; Bellissant E Drug Metab Pharmacokinet; 2013; 28(5):439-41. PubMed ID: 23545593 [TBL] [Abstract][Full Text] [Related]
10. A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis. Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y J Clin Pharm Ther; 2018 Dec; 43(6):849-854. PubMed ID: 29893015 [TBL] [Abstract][Full Text] [Related]
11. Correlation between enzyme multiplied immunoassay technique and high-performance liquid chromatography in the quantification of voriconazole in a paediatric population. Li X; Li W; Li M; Zhang Z; Liu S; Chen Z Scand J Clin Lab Invest; 2021 Apr; 81(2):121-126. PubMed ID: 33426972 [TBL] [Abstract][Full Text] [Related]
12. [Significance of the ratio of C-reactive protein to prealbumin in patients with traumatic brain injury]. Xu W; Ge Z; Cao J; Mao S; Ma K; Xia Z Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):965-969. PubMed ID: 32912411 [TBL] [Abstract][Full Text] [Related]
13. The impact of gene polymorphism and hepatic insufficiency on voriconazole dose adjustment in invasive fungal infection individuals. Li G; Li Q; Zhang C; Yu Q; Li Q; Zhou X; Yang R; Yang X; Liu H; Yang Y Front Genet; 2023; 14():1242711. PubMed ID: 37693307 [TBL] [Abstract][Full Text] [Related]
14. Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis. Gatti M; Fornaro G; Pasquini Z; Zanoni A; Bartoletti M; Viale P; Pea F Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107125 [TBL] [Abstract][Full Text] [Related]
15. Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT. Gatti M; Campoli C; Muratore E; Belotti T; Masetti R; Lanari M; Viale P; Pea F Microorganisms; 2024 Jul; 12(7):. PubMed ID: 39065156 [TBL] [Abstract][Full Text] [Related]
16. In Vivo Efficacy of Voriconazole in a Jemel S; Guillot J; Kallel K; Jouvion G; Brisebard E; Billaud E; Jullien V; Botterel F; Dannaoui E J Fungi (Basel); 2021 Nov; 7(12):. PubMed ID: 34946994 [No Abstract] [Full Text] [Related]
17. Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions. Ji Q; Huang B; Wang M; Ren Z; Zhang S; Zhang Y; Sheng L; Yu Y; Jiang J; Chen D; Ying J; Yu J; Qiu L; Wan R; Li W Exp Ther Med; 2014 Apr; 7(4):778-784. PubMed ID: 24669233 [TBL] [Abstract][Full Text] [Related]
18. Impact of Iontophoresis and PACK-CXL Corneal Concentrations of Antifungals in an In Vivo Model. Kalkanci A; Yesilirmak N; Ozdemir HB; Unal EA; Erdoğan M; Seker T; Tum AE; Karakus AK; Hizel K; Bilgihan K Cornea; 2018 Nov; 37(11):1463-1467. PubMed ID: 30161054 [TBL] [Abstract][Full Text] [Related]
19. Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection. Arora S; Haghi M; Loo CY; Traini D; Young PM; Jain S Mol Pharm; 2015 Jun; 12(6):2001-9. PubMed ID: 25923171 [TBL] [Abstract][Full Text] [Related]
20. Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan. Hamada Y; Ueda T; Miyazaki Y; Nakajima K; Fukunaga K; Miyazaki T; Nakada-Motokawa N; Nagao M; Kawamura H; Shigemi A; Ebihara F; Kimura T; Ikegame K; Uchino M; Ikeuchi H; Takesue Y Mycoses; 2020 Aug; 63(8):779-786. PubMed ID: 32510723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]